Preliminary results of metronomic capecitabine treatment in advanced hepatocellular carcinoma (HCC)

被引：0
|
作者：
Brandi, G.
Fanello, S.
Piscaglia, F.
Falanga, A.
Balducci, D.
Pantaleo, M. A.
Muscolo, P.
Derenzini, E.
Bolondi, L.
Biasco, G.
机构：
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [21] The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma
    Brandi, Giovanni
    Di Federico, Alessandro
    Rizzo, Alessandro
    De Lorenzo, Stefania
    Vasuri, Francesco
    Brocchi, Stefano
    Golfieri, Rita
    Morelli, Maria Cristina
    Frega, Giorgio
    Palloni, Andrea
    ANTI-CANCER DRUGS, 2022, 33 (01) : E781 - E783
  • [22] Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC)
    Muszbek, Noemi
    Evans, Rachel
    Remak, Edit
    Brennan, Victoria K.
    Colaone, Fabien
    Shergill, Suki
    Ross, Paul
    Mullan, Damian
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (01) : 147 - 154
  • [23] Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases
    Marinelli, Sara
    Granito, Alessandro
    Piscaglia, Fabio
    Renzulli, Matteo
    Stagni, Angela
    Bolondi, Luigi
    HEPATITIS MONTHLY, 2013, 13 (09)
  • [24] TRANSARTERIAL EMBOLIZATION (TAE) VS NO TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR-CARCINOMA (HCC) - PRELIMINARY-RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    CASTELLS, A
    BRUIX, J
    MONTANYA, X
    BRU, C
    AYUSO, MC
    BOIX, L
    RODES, J
    HEPATOLOGY, 1994, 19 (04) : I51 - I51
  • [25] Phase II Trial of Oral Capecitabine for the Treatment of Advanced Hepatocellular Carcinoma
    Anis, Muhammad
    Abbas, Zaigham
    Jafri, Wasim
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S120 - S120
  • [26] PHASE II STUDY OF EVEROLIMUS AND CAPECITABINE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (HCC). RESULTS OF THE FIRST 10 PATIENTS INCLUDED
    Luelmo, S.
    Osanto, S.
    Weijl, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 256 - 257
  • [27] Capecitabine in advanced hepatocellular carcinoma: a multicenter experience
    Pelizzaro, F.
    Sammarco, A.
    Pastorelli, D.
    Giovanis, P.
    Dadduzio, V.
    Rizzato, M. D.
    Lombardi, G.
    Lonardi, S.
    Peserico, G.
    Imondi, A.
    Sartori, A.
    Maddalo, G.
    Farinati, F.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E40 - E40
  • [28] SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH ADVANCED LIVER DISEASE
    Alves, Rogerio C.
    Alves, Daniele E.
    Guz, Betty
    Viana, Monica V.
    Harriz, Michelle C.
    Matos, Carla A.
    Terrabuio, Deborah
    Chagas, Aline
    Moutinho, Renata D.
    Taddeo, Eliane F.
    Duarte, Kelly C.
    Oliveira, George P.
    Ribeirol, Juliana M.
    Kondo, Mario
    Gampel, Otavio
    Poletti, Paula
    HEPATOLOGY, 2010, 52 (04) : 1193A - 1193A
  • [29] CAPECITABINE IN ADVANCED HEPATOCELLULAR CARCINOMA: A MULTICENTER EXPERIENCE
    Pelizzaro, F.
    Sammarco, A.
    Pastorelli, D.
    Giovanis, P.
    Dadduzio, V.
    Rizzato, M. D.
    Lombardi, G.
    Lonardi, S.
    Peserico, G.
    Imondi, A.
    Sartori, A.
    Maddalo, G.
    Farinati, F.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E96 - E96
  • [30] Capecitabine in advanced hepatocellular carcinoma: A multicenter experience
    Pelizzaro, Filippo
    Sammarco, Ambra
    Dadduzio, Vincenzo
    Pastorelli, Davide
    Giovanis, Petros
    Solda, Caterina
    Rizzato, Mario Domenico
    Lombardi, Giuseppe
    Lonardi, Sara
    Peserico, Giulia
    Imondi, Angela
    Sartori, Anna
    Maddalo, Gemma
    Farinati, Fabio
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (12) : 1713 - 1719
12345